Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Aveanna Healthcare Holdings (AVAH) over the last 6 years, with Q3 2025 value amounting to $419.1 million.

  • Aveanna Healthcare Holdings' Cost of Revenue rose 1997.97% to $419.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 1097.43%. This contributed to the annual value of $1.4 billion for FY2024, which is 686.17% up from last year.
  • Aveanna Healthcare Holdings' Cost of Revenue amounted to $419.1 million in Q3 2025, which was up 1997.97% from $378.8 million recorded in Q2 2025.
  • In the past 5 years, Aveanna Healthcare Holdings' Cost of Revenue ranged from a high of $419.1 million in Q3 2025 and a low of $271.5 million during Q4 2021
  • For the 5-year period, Aveanna Healthcare Holdings' Cost of Revenue averaged around $333.4 million, with its median value being $330.4 million (2023).
  • As far as peak fluctuations go, Aveanna Healthcare Holdings' Cost of Revenue plummeted by 1770.16% in 2022, and later skyrocketed by 1997.97% in 2025.
  • Over the past 5 years, Aveanna Healthcare Holdings' Cost of Revenue (Quarter) stood at $271.5 million in 2021, then rose by 18.72% to $322.4 million in 2022, then increased by 2.49% to $330.4 million in 2023, then rose by 5.37% to $348.2 million in 2024, then grew by 20.38% to $419.1 million in 2025.
  • Its Cost of Revenue stands at $419.1 million for Q3 2025, versus $378.8 million for Q2 2025 and $375.7 million for Q1 2025.